Crestchem Limited (BOM:526269)
India · Delayed Price · Currency is INR 131.15
+3.50 (2.74%)
At close: Jul 10, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 393.45 million as of July 10, 2026. Its market cap has decreased by -22.17% in one year.
Market Cap
393.45M
Enterprise Value
389.65M
Revenue
302.66M
Ranking
n/a
PE Ratio
14.52
Stock Price
131.15
Market Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 393.45M, an increase of 1,159.85%. That is a compound annual growth rate of 20.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 393.45M | 16.63% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.47B |
| Smruthi Organics | 1.40B |
| Tyche Industries | 1.25B |
| Krebs Biochemicals & Industries | 1.18B |
| Vasundhara Rasayans | 555.87M |
| Bacil Pharma | 550.87M |
| Alfavision Overseas (India) | 309.90M |
| Venmax Drugs and Pharmaceuticals | 223.78M |